Atlas Trials

Safety Study of RPE65 Gene Therapy to Treat Leber Congenital Amaurosis

Clinical trial NCT00643747 · COMPLETED

Trial details

NCT number
NCT00643747
Sponsor
University College, London
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Retinal Degeneration
Start date
2007-01-01
Primary completion
2014-12-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.